循环系统是由生物体内的细胞外液(包括血浆、淋巴和组织液)及其流动管道组成的系统。自动物形成心脏后,该系统分为两大部分:心脏和血管,称为心血管系统。循环系统作为生物体内的运输系统,负责将消化道吸收的营养物质以及由鳃或肺摄取的氧气输送到各组织器官,并通过同样的途径将这些组织器官产生的代谢产物带回血液中,再经肺、肾排出体外。此外,它还承担着输送热量到全身以维持体温和运送激素至靶器官以调节其功能的任务。
循环系统的药物主要包括抗心绞痛药、抗心律失常药、抗高血压药、用于治疗休克的血管活性药、调节血脂药及预防动脉粥样硬化的药物、周围血管扩张药、钙拮抗剂、抗心力衰竭药以及治疗慢性心功能不全的药物。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
—— | (S)-(5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl)-(6-methoxyquinolin-4-yl)methanol;sulfuric acid | 50-54-4 | C40H50N4O8S |
|
—— | "Saxagliptin (BMS-477118,Onglyza)" | 361442-04-8 | C18H25N3O2 |
|
—— | 8-(beta-D-Glucopyranosyl)-4',7-dihydroxyisoflavone | 3681-99-0 | C21H20O9 |
|
—— | (3S,5R,E)-tert-Butyl 7-(3-(4-fluorophenyl)-1-isopropyl-1H-indol-2-yl)-3,5-dihydroxyhept-6-enoate | 129332-29-2 | C28H34FNO4 |
|
—— | Bisoprolol; butenedioic acid | 104344-23-2 | C22H35NO8 |
|
—— | Hesperetin-rutinoside | 520-26-3 | C28H34O15 |
|
—— | calcium;(E,3S,5S)-7-[4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoate | 147098-20-2 | C44H54CaF2N6O12S2 |
|
—— | Pharmakon1600-01505803 | 81131-70-6 | C23H36NaO7+ |
|
—— | [(1R,2S)-1-hydroxy-1-(3-hydroxyphenyl)propan-2-yl]azanium;(2R,3S)-2,3,4-trihydroxy-4-oxobutanoate | 33402-03-8 | C13H19NO8 |
|
—— | Crestor (TN) | 147098-20-2 | C22H28CaFN3O6S+2 |
|
—— | 2-(diethylamino)ethyl (2S)-2-(naphthalen-1-ylmethyl)-3-[(2R)-oxolan-2-yl]propanoate;oxalic acid | 3200-06-4 | C2H2O4*C24H33NO3 |
|
—— | (2S,4S)-4-cyclohexyl-1-[2-[[(1R)-2-methyl-1-propanoyloxypropoxy]-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid | 98048-97-6 | C30H46NO7P |
|
—— | R-Timolol 2-butenedioate | 26839-77-0 | C17H28N4O7S |
|
—— | Fosinopril | 98048-97-6 | C30H46NO7P |
|
—— | rac-Rosuvastatin Sodium Salt (Mixture: R700515 and Sodium Salt of R700500) | 147098-18-8 | C22H27FN3NaO6S |
|
—— | 2-(diethylamino)ethyl (2R)-2-(naphthalen-1-ylmethyl)-3-[(2R)-oxolan-2-yl]propanoate;oxalic acid | 3200-06-4 | C2H2O4*C24H33NO3 |
|
—— | 2-(diethylamino)ethyl (2R)-2-(naphthalen-1-ylmethyl)-3-[(2S)-oxolan-2-yl]propanoate;oxalic acid | 3200-06-4 | C2H2O4*C24H33NO3 |
|
—— | 2-(diethylamino)ethyl (2S)-2-(naphthalen-1-ylmethyl)-3-[(2S)-oxolan-2-yl]propanoate;oxalic acid | 3200-06-4 | C2H2O4*C24H33NO3 |
|
—— | Sodium;6-[[22-[(3-acetyloxy-2-methylbutanoyl)oxymethyl]-21-hydroxy-8-(hydroxymethyl)-3,4,8,12,19,19-hexamethyl-23-oxahexacyclo[18.2.1.03,16.04,13.07,12.017,22]tricos-15-en-9-yl]oxy]-4-hydroxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-5-(3,4,5-trihydroxyoxan-2-yl)oxyoxane-2-carboxylic acid | 20977-05-3 | C54H84NaO23+ |
|
—— | Cozaar | 124750-99-8 | C22H22ClN6O- |
|
—— | L(-)-Norepinephrine bitartrate | 51-40-1 | C12H17NO9 |
|
—— | Carvedilol Phosphate | 610309-89-2 | C48H60N4O17P2 |
|
—— | (2R,3S)-2,3-dihydroxybutanedioic acid;1-[4-(2-methoxyethyl)phenoxy]-3-(propan-2-ylamino)propan-2-ol | 56392-17-7 | C34H56N2O12 |
|
—— | 4-amino-1-(2R-hydroxymethyl-[1,3]oxathiolan-5S-yl)-1H-pyrimidin-2-one salicylate | 173522-96-8 | C15H15N3O5S |
|
—— | Levalbuterol Tartrate | 661464-94-4 | C30H48N2O12 |
|
—— | mibefradil dihydrochloride | 116666-63-8 | C29H38FN3O3*2ClH |
|
—— | cinepazide maleate | 28044-44-2 | C4H4O4*C22H31N3O5 |
|
—— | 147098-20-2 (Calcium) | 147098-20-2 | C44H54CaF2N6O12S2 |
|
—— | Hydroquinidine 4-methyl-2-quinolyl ether | 135042-89-6 | C30H33N3O2 |
|
—— | (6R)-2,6-dimethylpiperidine | 504-03-0 | C7H15N |
|
—— | (1R,2R,9S,10S)-7,15-diazatetracyclo[7.7.1.02,7.010,15]heptadecane;sulfuric acid | 6160-12-9 | C15H28N2O4S |
|
—— | [R-(R*,R*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid | 344423-98-9 | C33H34FN2O5 |
|
—— | Fluvastatin acid | 93957-54-1 | C24H26FNO4 |
|
—— | methyl (2S,9R,10R,11S,14R,15S,17R)-2,15-dimethyl-5,5'-dioxospiro[18-oxapentacyclo[8.8.0.01,17.02,7.011,15]octadec-6-ene-14,2'-oxolane]-9-carboxylate | 107724-20-9 | C24H30O6 |
|
—— | (E)-but-2-enedioic acid;(E)-1-[4-(2-oxo-2-pyrrolidin-1-ylethyl)piperazin-1-yl]-3-(3,4,5-trimethoxyphenyl)prop-2-en-1-one | 26328-04-1 | C26H35N3O9 |
|
—— | fosinopril sodium | 88889-14-9 | C30H45NO7P*Na |
|
—— | Azimilide hydrochloride | 149888-94-8 | C23H30Cl3N5O3 |
|
—— | methyl (5Z)-4-[2-[2-(3,4-dihydroxyphenyl)ethoxy]-2-oxoethyl]-5-ethylidene-6-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4H-pyran-3-carboxylate | 32619-42-4 | C25H32O13 |
|
—— | tert-butyl (3S,5R)-7-[3-(4-fluorophenyl)-1-propan-2-ylindol-2-yl]-3,5-dihydroxyhept-6-enoate | 129332-29-2 | C28H34FNO4 |
|
—— | (2S)-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxy-2,3-dihydrochromen-4-one | 520-26-3 | C28H34O15 |
|
—— | (E)-7-[4-(4-fluorophenyl)-5-(methoxymethyl)-2,6-di(propan-2-yl)pyridin-3-yl]-3,5-dihydroxyhept-6-enoic acid | 145599-86-6 | C26H34FNO5 |
|
—— | cerivastatin sodium | 143201-11-0 | C26H33FNO5*Na |
|
—— | (4R)-4-[(3R,5R,6S,10R,13R,17R)-3,6-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid | 83-49-8 | C24H40O4 |
|
—— | Methylhesperidin | 11013-97-1 | C29H36O15 |
|
—— | 4-[(1S)-2-amino-1-hydroxyethyl]benzene-1,2-diol;2,3-dihydroxybutanedioic acid | 51-40-1 | C12H17NO9 |
|
—— | (Z)-methyl 4-(2-(3,4-dihydroxyphenethoxy)-2-oxoethyl)-3-ethylidene-2-((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy)-3,4-dihydro-2H-pyran-5-carboxylate | 32619-42-4 | C25H32O13 |
|
—— | Isosparteine, alpha | 90-39-1 | C15H26N2 |
|
—— | 1-(Isopropylamino)-3-(p-[beta-methoxyethyl]phenoxy)-2-propanol tartrate | 56392-17-7 | C34H56N2O12 |
|
—— | erythritol tetranitrate | 7297-25-8 | C4H6N4O12 |
|
—— | hesperidin | 520-27-4 | C28H32O15 |
|